Turning Patient Engagement into Brand, Business and Patient Outcomes

Format: Invite-Only Executive Roundtable
Location: HLTH USA
Timing: Monday, 8:30–10:00 a.m.

Pharma has invested significantly in digital patient engagement, yet many initiatives remain fragmented, difficult to scale or disconnected from broader brand strategy. At the same time, AI, consented patient data, digital communities and direct-to-patient engagement models are creating new opportunities to understand patient needs, personalise support, and build stronger relationships throughout the treatment journey. The challenge is no longer whether pharma should invest in digital engagement, but where it can make a meaningful difference and how that impact can be demonstrated.

Hosted by HLTH in partnership with Aptar Digital Health, this invite-only roundtable will bring together senior pharmaceutical leaders for a candid, peer-led discussion on moving digital patient engagement beyond pilots and isolated programs. Participants will share practical examples and explore how digital solutions can support launch and lifecycle strategy, turn real-world patient insight into action, and generate measurable value for patients, brands and the wider business. 

The conversation will be particularly relevant to leaders working in chronic and complex conditions, including neurology, multiple sclerosis, immunology and dermatology, where the patient journey often extends well beyond treatment initiation and sustained support can influence activation, adherence, persistence and outcomes. 

The discussion will explore:

• Moving from Isolated Pilots to Lifecycle Strategy
• Turning External Platforms into Actionable Insights
• Personalization at Scale in the Age of AI
• Delivering Value Beyond Engagement Metrics

Participants will leave with:

• A clearer view of where digital patient engagement can create strategic value across the brand lifecycle.

• peer connections and perspectives on scaling programs.

• practical ideas for using patient insight, AI and direct engagement more effectively. 

• A sharper framework for demonstrating impact on patients, brand and business.